Frank Ruffo
Director/Board Member bei Aclaris Life Sciences, Inc.
Aktive Positionen von Frank Ruffo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Director/Board Member | - | - |
Corporate Secretary | - | - | |
Treasurer | - | - |
Karriereverlauf von Frank Ruffo
Ehemalige bekannte Positionen von Frank Ruffo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ACLARIS THERAPEUTICS, INC. | Director of Finance/CFO | 01.07.2012 | 31.12.2022 |
Founder | 01.07.2012 | 31.12.2022 | |
Investor Relations Contact | 01.07.2012 | - | |
Corporate Secretary | 01.07.2012 | 01.08.2015 | |
Treasurer | 01.07.2012 | 31.12.2022 | |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Director of Finance/CFO | 01.10.2011 | 01.11.2014 |
BioLeap, Inc.
BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Director of Finance/CFO | 01.01.2010 | 01.01.2013 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Director of Finance/CFO | 05.11.2009 | 01.07.2011 |
Founder | 01.08.2009 | 01.07.2011 | |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Director of Finance/CFO | 01.01.1996 | - |
Cabot Medical Corp.
Cabot Medical Corp. Medical SpecialtiesHealth Technology Cabot Medical Corp. designs and manufactures medical instruments. The firm offers endoscopes, light source, adapter optics, and other electrosurgical instruments. The company is headquartered in Langhorne, PA. | Corporate Officer/Principal | 01.01.1991 | - |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 01.01.1991 | 01.01.1991 |
Ausbildung von Frank Ruffo
LaSalle University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 2 |
Operativ
Director of Finance/CFO | 5 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ACLARIS THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Cabot Medical Corp.
Cabot Medical Corp. Medical SpecialtiesHealth Technology Cabot Medical Corp. designs and manufactures medical instruments. The firm offers endoscopes, light source, adapter optics, and other electrosurgical instruments. The company is headquartered in Langhorne, PA. | Health Technology |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Health Technology |
Venatorx Pharmaceuticals, Inc.
Venatorx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Venatorx Pharmaceuticals, Inc. develops novel anti-infective agents to address the threat of antibiotic resistance. It offers antibiotic resistant bacteria and Carbapenem-resistant Enterobacteriaceae a family of gram-negative bacteria that are resistant to all known ?-lactam antibiotics, including penicillins, cephalosporins, monobactams, and carbapenems. The company was founded by Christopher J. Burns, Luigi Xerri, and Daniel Pevear in 2010 and is headquartered in Malvern, PA. | Commercial Services |
BioLeap, Inc.
BioLeap, Inc. Pharmaceuticals: MajorHealth Technology BioLeap, Inc. discovers, designs and develops drug pharmaceutical products. Its process creates novel compounds with intellectual property protection, enhances the intellectual property estate around existing compounds, avoids obstructive patents and generates fast-follower compounds. The company was founded by Gerald H. Evans and John L. Kulp in 2004 and is headquartered in Pennington, NJ. | Health Technology |
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Börse
- Insiders
- Frank Ruffo
- Erfahrung